Characteristic | Report of pagophagia (n = 103)2 | Pica without report of ice (n = 15) | Value of p3 |
---|---|---|---|
Age, y | 49 ± 15 | 52 ± 18 | 0.5056 |
Women, % (n) | 90.3 (93) | 100.0 (15) | 0.2421 |
White, % (n) | 74.8 (77) | 80.0 (12) | 0.4693 |
Body mass index, kg/m2 | 29.7 ± 7.6 | 30.1 ± 11.2 | 0.8857 |
Fatigue, % (n) | 45.6 (47) | 53.3 (8) | 0.5764 |
Cardiopulmonary symptoms, % (n) | 42.7 (44) | 46.7 (7) | 0.7730 |
Epithelial manifestations, % (n) | 26.2 (27) | 53.3 (8) | 0.0361 |
Mental symptoms, % (n) | 6.8 (7) | 0 (0) | 0.3758 |
Neuromuscular symptoms, % (n) | 6.8 (7) | 0 (0) | 0.3758 |
Gastrointestinal blood loss, % (n) | 36.9 (38) | 33.3 (5) | 0.7890 |
Reproductive blood loss, % (n) | 43.7 (45) | 20.0 (3) | 0.0684 |
Epistaxis, % (n) | 0 (0) | 0 (0) | - |
Hematuria, % (n) | 1.0 (1) | 0 (0) | 0.8729 |
Medical blood loss, % (n) | 5.8 (6) | 20.0 (3) | 0.0877 |
Chronic malabsorption, % (n) | 8.7 (9) | 40.0 (6) | 0.0007 |
Unknown cause of iron deficiency/depletion, % (n) | 8.7 (9) | 6.7 (1) | 0.7879 |
Hemoglobin, g/L | 99 ± 21 | 110 ± 26 | 0.2471 |
MCV, fL | 73.8 ± 13.1 | 82.7 ± 8.9 | 0.0026 |
RBC × 1012/L | 4.16 ± 0.58 | 4.11 ± 0.95 | 0.8764 |
RDW, % | 18.7 ± 3.9 | 17.7 ± 2.3 | 0.1637 |
Platelets × 109/L | 336 ± 118 | 464 ± 247 | 0.0669 |
Lymphocytes × 109/L | 1.8 ± 0.8 | 2.2 ± 0.7 | 0.1012 |
Neutrophils × 109/L | 4.2 ± 2.1 | 4.8 ± 2.0 | 0.3587 |
SI, μmol/L | 7 ± 5 | 7 ± 4 | 0.8412 |
TIBC, μmol/L | 75 ± 13 | 77 ± 3 | 0.5761 |
TS, % | 9 ± 8 | 9 ± 6 | 0.8805 |
SF, pmol/L | 27 ± 22 | 27 ± 5 | 0.8883 |
Cancer in remission, % | 8.7 (9) | 0 (0) | 0.2807 |
CVID, % | 9.7 (10) | 20.0 (3) | 0.2154 |
Diabetes mellitus, % | 13.6 (14) | 0 (0) | 0.1319 |
Hemochromatosis, % | 1.0 (1) | 0 (0) | 0.8729 |
Anemia, % (n) | 81.6 (84) | 66.7 (10) | 0.1808 |
Thrombocytosis, % (n) | 16.5 (17) | 46.7 (7) | 0.0067 |
Thrombocytopenia, % (n) | 2.9 (3) | 6.7 (1) | 0.4432 |
Iron deficiency, % (n) | 68.0 (70) | 66.7 (10) | 0.9201 |
Iron deficiency with anemia, % (n) | 55.3 (57) | 40.0 (6) | 0.2658 |